Welcome to JN-International Medical Corporation [JN], a U.S. based private  biopharmaceutical corporation, has been developing vaccines for infectious disease and neurological disorders. Scientific Discovery since 1998 




United States - JN International Exports


JN exports vaccines & diagnostics to over 24 countries since 1999



News Highlights




2011 FDA authorized JN's IND for conducting Conjugated Meningococcal vaccine human trials in Hanford, California



2011 Neurology scientists bag Neurology Research Award from President Obama stimulus Grant



2006-2011 Meningitis vaccine for Disease outbreaks in India & sub-Saharan Africa






Dr.Reddy & Mr. Hankins at Pharmaceutical conference in Amsterdam





- Meningitis vaccine

- Vaccine for all ages

- Stroke therapeutic


The corporation 

JNI Medical Corp - Admin Building

Do you Know? JN is the 3rd BioPharma, developed patented Meningococcal meningitis serogroups A/C/Y/W135 diphtheria toxoid conjugate vaccine (NmVac-4dt).


* "Promising New Studies Attempts to Perfect a Genital Herpes & Meningitis serogroup 'B' vaccines."  


Inc5000 Fastest Growing Company.




Meningitis outbreaks  

Vaccine: NmVac4-ACYW135 DTNmVac-4dt is among the most complex biotech or biologic products. It’s a combination vaccine that contains four 4 different vaccines in one and can be used with any combination by the geographic prevalence of the disease causing serogroup A, C, Y & W-135



Neurological THERAPIES
Proof of concept of stroke and neurological diseases


Research & Development


    Pre-Clinical trial highlights


  • * Our Vaccine saves mice

  • * NMDA Auto Antibodies

  • * Neurologist's Biomarkers 

  • * TIA / Stroke therapeutic   




Filled Commitment



JN & Clinton Global


US President Malaria Initiative & JN International Medical Corporation


 © 1998 -2012 Jeeri Neotech International, Inc. Oakland, Nebraska 68045, USA . BYLAWS TERMS OF USE LEGAL DISCLAIMER